BST1 and depressive symptom measurement: Although no differences between genotypes were detected in DA content or turnover in the brain regions examined (cortex, striatum, amygdala and hippocampus) after the FST, the dopaminergic agents pramipexole, selegiline and rasagiline alleviated depression-like behavior in CD157 KO mice.